Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy

OBJECTIVE(S): Program death 1 (PD-1)/ program death-ligand 1 (PD-L1) pathways, as the main inhibitory checkpoints, induce immunosuppression in the tumor microenvironment (TME). Despite the importance of inhibitor checkpoint receptor (ICR) blockers, their outcomes have been limited by the low immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazdani, Mona, Hatamipour, Mahdi, Alani, Behrang, Nikzad, Hossein, Mohamadian Roshan, Nema, Verdi, Javad, Jaafari, Mahmoud Reza, Noureddini, Mahdi, Badiee, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478250/
https://www.ncbi.nlm.nih.gov/pubmed/32952954
http://dx.doi.org/10.22038/ijbms.2020.46654.10762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478250/
https://www.ncbi.nlm.nih.gov/pubmed/32952954
http://dx.doi.org/10.22038/ijbms.2020.46654.10762

Ejemplares similares